Novartis Pharmaceuticals Corporation v. Apotex Inc., et al. > Summary
Court Case Number 1:18-cv-01038
Filing Date Jul 13, 2018
Termination Date Apr 20, 2022
Court Delaware District Court
Status Dismissed - Settled
JudgesLeonard P. Stark
Plaintiff
Defendant
Plaintiff Attorneys
7Novartis
Attorney Name: Andrew Philip Blythe
Gibson Dunn & Crutcher
Novartis
Attorney Name: Michael P. Kelly
McCarter & English
Novartis
Attorney Name: Jane M. Love
Gibson Dunn & Crutcher
Novartis
Attorney Name: Daniel M. Silver
McCarter & English
Novartis
Attorney Name: Benjamin A. Smyth
McCarter & English
Novartis
Attorney Name: Robert W. Trenchard
Gibson Dunn & Crutcher
Novartis
Attorney Name: Paul E. Torchia
Gibson Dunn & Crutcher
Defendant Attorneys
7Apotex
Attorney Name: Dennis D. Gregory
Wilson Sonsini Goodrich & Rosati
Apotex
Attorney Name: Tung-On Kong
Wilson Sonsini Goodrich & Rosati
Apotex
Attorney Name: Diyang Liu
Wilson Sonsini Goodrich & Rosati
Apotex
Attorney Name: David E. Moore
Potter Anderson & Corroon
Apotex
Attorney Name: Bindu A. G. Palapura
Potter Anderson & Corroon
Attorney Name: Mary Procaccio-Flowers
Attorney Name: John C. Phillips, Jr.
Counter Defendant
6Novartis
Attorney Name: Andrew Philip Blythe
Gibson Dunn & Crutcher
Novartis
Attorney Name: Jane M. Love
Gibson Dunn & Crutcher
Novartis
Attorney Name: Benjamin A. Smyth
McCarter & English
Novartis
Attorney Name: Robert W. Trenchard
Gibson Dunn & Crutcher
Novartis
Attorney Name: Michael P. Kelly
McCarter & English
Novartis
Attorney Name: Daniel M. Silver
McCarter & English
Counter Claimant
Apotex
Attorney Name: David E. Moore
Potter Anderson & Corroon
Cause
35:1 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09187405 | S1P receptor modulators for treating relasping-remitting multiple sclerosis | Nov 17, 2015 |
